Showing results (371-380 of 668) with videos related to
Sort By:
Pageof 67
Hemasphere|September 5, 2020
Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic PurpuraLeydi C Velasquez Pereira, Bogac Ercig, Kadri Kangro, et al.Hemasphere|September 9, 2020
JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future PerspectivesPrithviraj Bose, Srdan VerstovsekHemasphere|December 7, 2020
A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease ComplexityMatteo C Da Vià, Bachisio Ziccheddu, Akihiro Maeda, et al.Hemasphere|November 22, 2021
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French ExperienceAnne Sophie Alary, Carole Maute, Olivier Kosmider, et al.Hemasphere|December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaGraham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.Hemasphere|February 22, 2021
Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell TransplantationDominic Brauer, Donata Backhaus, Rosmarie Pointner, et al.Hemasphere|September 9, 2022
What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice ExperimentLuca Laurenti, Gianluca Gaidano, Francesca Romana Mauro, et al.Hemasphere|August 24, 2022
Precision Medicine and Sickle Cell DiseaseSara El Hoss, Wassim El Nemer, David C ReesHemasphere|May 10, 2021
Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA TrialRuben A Mesa, Nicolaas Schaap, Alessandro M Vannucchi, et al.Pageof 67